Results 21 to 30 of about 95,376 (339)
JEADV Clinical Practice, 2023 Background Eosinophilia is common in patients with atopic dermatitis (AD). Abrocitinib, an oral Janus kinase‐1 inhibitor and dupilumab, an anti–interleukin‐4 receptor‐α antibody, are approved for moderate‐to‐severe AD.
Delphine Staumont‐Sallé +12 more
doaj +1 more source
Permutation inference methods for multivariate meta-analysis [PDF]
Biometrics 2020;76(1):337-347, 2018 Multivariate meta-analysis is gaining prominence in evidence synthesis research because it enables simultaneous synthesis of multiple correlated outcome data, and random-effects models have generally been used for addressing between-studies heterogeneities.
arxiv +1 more source
Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).
Revista da Associação Médica Brasileira, 2016 OBJECTIVE To review the hypersensitivity reaction to drugs known as drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), based on a case report. We also intend to discuss the difficulty and importance of disease recognition, since none
S. Silva +4 more
semanticscholar +1 more source
Refractory nummular eczema in child successfully treated with NB‐UVB and topical delgocitinib
, 2022 Journal of Cutaneous Immunology and Allergy, Volume 5, Issue 6, Page 229-230, December 2022.
Ichiro Kurokawa, Jun‐Ichiro Ono
wiley +1 more source
Evidence of helminthic infestation and efficacy of anthelminthic treatment in children investigated for eosinophilia [PDF]
Vojnosanitetski PregledBackground/Aim. The cause of eosinophilia often remains unelucidated. The aim of the study was to analyze causes and treatment approaches in children with eosinophilia in pediatric tertiary care hospital. Methods.
Rodić Predrag +6 more
doaj +1 more source
Study on Peripheral Eosinophilia among Paediatric Patients in a Tertiary Care Hospital [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Eosinophilia may be due to primary or secondary causes. They are divided based on absolute eosinophil count as: mild (less than 1500 cells per cubic millimeter); moderate (1500 to 5000 cells per cubic millimeter); and severe (more than 5000
Madhumitha Senthilnathan Sasikala +3 more
doaj +1 more source
Al-Azhar Assiut Medical Journal, 2018 Background Blood eosinophilia was considered an indicator of sputum eosinophilia in asthmatic patients. Nevertheless, its role in chronic obstructive pulmonary disease (COPD) was not completely examined. Aim The aim was to investigate if peripheral blood
Atef W El Rifai, Hussein A.M Hussein
doaj +1 more source
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
European Respiratory Journal, 2017 The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains controversial. To evaluate the prevalence and stability of a high level of blood eosinophils (≥300 cells·μL–1) and its relationship to outcomes, we determined blood ...
C. Casanova +28 more
semanticscholar +1 more source
RMD Open, 2015 Objectives To determine the prevalence of eosinophilia in patients with recent-onset arthritis suggestive of rheumatoid arthritis (RA) and to describe their features and outcomes.Methods We performed an ancillary study of data from a French prospective ...
Sandrine Jousse-Joulin +9 more
doaj +1 more source
Artificial Intelligence-based Eosinophil Counting in Gastrointestinal Biopsies [PDF]
arXiv, 2022 Normally eosinophils are present in the gastrointestinal (GI) tract of healthy individuals. When the eosinophils increase beyond their usual amount in the GI tract, a patient gets varied symptoms. Clinicians find it difficult to diagnose this condition called eosinophilia. Early diagnosis can help in treating patients.
arxiv